Newly appointed President Europe of rapidly expanding global specialized pharmaceutical giant EUSA, which focuses on treatment and cure of rare diseases and oncology care, Carsten Thiel brings over twenty years of pertinent experience within the pharmaceutical sector to his new role. Responsible for growing the company’s European infrastructure, Thiel holds a PhD in Molecular Biology & Biochemistry and parlays previously perfected skills within this multifaceted leadership role.
Full story: https://www.bizjournals.com/newyork/potmsearch/detail/submission/6471941/Carsten_Thiel